 |
Lotus Pharmaceuticals Enter R-Bambuterol® Clinical Trial I 2010/08/26 |
|
Lotus Pharmaceuticals Reports Strong Second Quarter 2010 Financial Results 2010/08/16 |
|
Lotus Completed R-Bambuterol¡¯s Pilot Scale Production for Clinical Trials 2010/08/03 |
|
Lotus Pharmaceuticals Terminates SEDA 2010/07/22 |
|
Lotus Pharmaceuticals, Inc. Reports Strong First Quarter 2010 Financial Results 2010/05/14 |
|
Lotus Pharmaceuticals¡¯ Laevo-Bambuterol Received SFDA Approval to Commence Clinical Trials 2010/04/29 |
|
Lotus Pharmaceuticals¡¯ Innovative Drug to Receive SFDA Fast Track Approval 2010/04/20 |
|
Lotus Pharmaceuticals, Inc. Reports Full Year 2009 Financial Results 2010/04/01 |
|
Lotus Pharmaceuticals Reports Groundbreaking Ceremony 2010/03/10 |
|
YA Global Master SPV Ltd Invests up to US$10,000,000 in Lotus Pharmaceutical, Inc. through Equity Line Facility 2010/03/03 |
|
Lotus Pharmaceuticals
Announces New Prescription Drugs 2010/03/02 |
|
Lotus Pharmaceuticals to Commence Sarbanes-Oxley Compliance Project 2010/03/01 |
|
Lotus Pharmaceuticals
Announces Key Changes 2010/01/15 |
|
Lotus Pharmaceuticals, Inc.
Appoints OTC Division Head 2009/12/10 |
|
Lotus Pharmaceuticals, Inc. Strengthens Beijing Presence with Direct Sales to Drug Stores 2009/11/30 |
|
Lotus Pharmaceuticals, Inc. to Exhibit at the 62nd
PHARMCHINA
2009/11/24 |
|
Lotus
Pharmaceuticals,Inc. Reports Third-Quarter 2009 Results
2009/11/16 |
|
Lotus
Pharmaceuticals,Inc. Announces Certain Clarification 2009/11/05 |
|
Lotus Pharmaceuticals, Inc. Announces 2010 Growth Strategy 2009/10/19
|
|
|
Lotus Reports Second Quarter 2009 Financial Results 2009/08/14 |
|
|
Lotus Pharmaceuticals, Inc. Announces Patent Pending Gliclazide-Controlled Release Tablets 2009/07/30 |
|
|
Lotus Pharmaceuticals, Inc. Again Awarded GSP Certification 2009/06/29
|
|
|
Lotus Pharmaceuticals, Inc. Reports First Quarter 2009
Financial Results 2009/05/18 |
|
|
Lotus Pharmaceuticals, Inc. Reports Strong 2008 Financial Results 2009/04/22 |
|
|
Lotus Pharmaceuticals, Inc. Purchases Intellectual Property
Rights to an Established Prescription Drug 2009/02/18 |
|
|
Lotus Pharmaceuticals, Inc. Purchases Land Use Rights to
Grow its Business and Reduce Costs 2009/02/05 |
|
|
Lotus Pharmaceuticals Announces Third Quarter 2008 Results 2008/11/18 |
|
|
Lotus Pharmaceuticals Announces Second Quarter 2008 Results 2008/08/18 |
|
|
|
|
|
Lotus Pharmaceuticals, Inc. Reaffirms its Confidence in
Meeting its Make Good Target for Fiscal Year 2008 2008/05/30 |
|
|
|
|
|
Lotus Pharmaceuticals, Inc. Announces Resignation of Director Mel Rothberg 2008/04/24
|
|
|
Lotus Pharmaceuticals, Inc. Announces Fourth Quarter and
Fiscal Year 2007 Results 2008/04/17 |
|
|
Lotus Pharmaceuticals Raises $5 Million in Private Placement 2008/02/26 |
|
|
Lotus Pharmaceuticals, Inc. Implements
Environmentally-friendly Cost Saving Strategies 2008/02/07 |
|
|
Lotus Pharmaceuticals, Inc. Achieves Significant Milestones
in the Development of Isosorbide Mononitrate Sustained
Release Tablets 2008/02/26 |
| ¡¡ |
¡¡ |
